Literature DB >> 3981201

Isoniazid and action tremor in multiple sclerosis.

J Morrow, H McDowell, C Ritchie, V Patterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3981201      PMCID： PMC1028268          DOI： 10.1136/jnnp.48.3.282

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

Review 1.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

2.  Isoniazid-associated hepatitis in 114 patients.

Authors:  M Black; J R Mitchell; H J Zimmerman; K G Ishak; G R Epler
Journal:  Gastroenterology       Date:  1975-08       Impact factor: 22.682

3.  A double-blind clinical trial of isoniazid in Huntington disease.

Authors:  T L Perry; J M Wright; S Hansen; S M Thomas; B M Allan; P A Baird; P A Diewold
Journal:  Neurology       Date:  1982-04       Impact factor: 9.910

4.  Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid.

Authors:  K V Rao; D A Mitchison; N G Nair; K Prema; S P Tripathy
Journal:  Br Med J       Date:  1970-08-29

5.  Treatment of action tremor in multiple sclerosis with isoniazid.

Authors:  A F Sabra; M Hallett; L Sudarsky; W Mullally
Journal:  Neurology       Date:  1982-08       Impact factor: 9.910
  5 in total
  10 in total

1.  Isoniazid and action tremor in multiple sclerosis.

Authors:  M Hallett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

Review 2.  Movement Disorders in Multiple Sclerosis: An Update.

Authors:  Ritwik Ghosh; Dipayan Roy; Souvik Dubey; Shambaditya Das; Julián Benito-León
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2022-05-04

Review 3.  Neurological manifestations and toxicities of the antituberculosis drugs. A review.

Authors:  M R Holdiness
Journal:  Med Toxicol       Date:  1987 Jan-Feb

4.  A controlled trial of isoniazid therapy for action tremor in multiple sclerosis.

Authors:  C B Bozek; L F Kastrukoff; J M Wright; T L Perry; T A Larsen
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

5.  Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry.

Authors:  William Meador; Amber R Salter; John R Rinker
Journal:  Int J MS Care       Date:  2016 May-Jun

6.  Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.

Authors:  Andrés Labiano-Fontcuberta; Julián Benito-León
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-09-14

Review 7.  Tremor in multiple sclerosis.

Authors:  Marcus Koch; Jop Mostert; Dorothea Heersema; Jacques De Keyser
Journal:  J Neurol       Date:  2007-02-21       Impact factor: 4.849

8.  Intention tremor and deficits of sensory feedback control in multiple sclerosis: a pilot study.

Authors:  Megan Heenan; Robert A Scheidt; Douglas Woo; Scott A Beardsley
Journal:  J Neuroeng Rehabil       Date:  2014-12-19       Impact factor: 4.262

Review 9.  Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Alastair Wilkins
Journal:  Front Neurol       Date:  2017-06-28       Impact factor: 4.003

10.  Upper Limb Intention Tremor in Multiple Sclerosis: An Evidence-Based Review of Assessment and Treatment.

Authors:  J Keiko McCreary; James A Rogers; Susan J Forwell
Journal:  Int J MS Care       Date:  2018 Sep-Oct
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.